loadpatents
Patent applications and USPTO patent grants for St-Denis; Yves.The latest application filed is for "condensed n-heterocyclic compounds and their use as crf receptor antagonists".
Patent | Date |
---|---|
Condensed N-Heterocyclic Compounds and their Use as CRF Receptor Antagonists App 20110172255 - Andreotti; Daniele ;   et al. | 2011-07-14 |
N-phenyl Hydrazides As Modulators Of The Ghrelin Receptor App 20100286152 - Bernasconi; Giovanni ;   et al. | 2010-11-11 |
Methods for the treatment of sleep disorders Grant 7,625,904 - Alvaro , et al. December 1, 2 | 2009-12-01 |
Pyrrolo[2, 3-d] pyrimidine derivatives as corticotropin releasing factor antagonists Grant 7,462,622 - Di Fabio , et al. December 9, 2 | 2008-12-09 |
Tri-and tetraaza-acenaphthylen derivatives as CRF receptor antagonists Grant 7,446,108 - Di Fabio , et al. November 4, 2 | 2008-11-04 |
Chemical Compounds App 20080249108 - Alvaro; Giuseppe ;   et al. | 2008-10-09 |
Condensed N-heterocyclic compounds and their use as CRF receptor antagonists Grant 7,427,630 - Di Fabio , et al. September 23, 2 | 2008-09-23 |
Chemical compounds Grant 7,345,041 - Alvaro , et al. March 18, 2 | 2008-03-18 |
CRF receptor antagonists Grant 7,329,667 - Di Fabio , et al. February 12, 2 | 2008-02-12 |
Chemical compounds Grant RE39,921 - Alvaro , et al. November 13, 2 | 2007-11-13 |
Substituted pyrrolo[2,3-d]pyrimidines as antagonists of the corticotropin releasing factor (CRF) Grant 7,279,474 - Capelli , et al. October 9, 2 | 2007-10-09 |
Phenyl-5,6,6A,7,8,9-hexahydro-4H-1,4,9-triaza-phenalene derivatives as CRF antagonists Grant 7,273,871 - Di Fabio , et al. September 25, 2 | 2007-09-25 |
Chemical Compounds App 20070219232 - Di Fabio; Romano ;   et al. | 2007-09-20 |
Chemical compounds Grant 7,253,284 - Di Fabio , et al. August 7, 2 | 2007-08-07 |
Heteroaryl-substituted pyrrolo'2,3-b1 pyridine derivatives as crf receptor antagonists App 20070066640 - Castiglioni; Emiliano ;   et al. | 2007-03-22 |
Condensed n-heterocyclic compounds and their use as crf receptor antagonists App 20070021429 - St-Denis; Yves | 2007-01-25 |
Condensed n-heterocyclic compounds and their use as crf receptor antagonists App 20070004708 - Andreotti; Daniele ;   et al. | 2007-01-04 |
Chemical compounds Grant 7,071,196 - Alvaro , et al. July 4, 2 | 2006-07-04 |
Chemical compounds App 20060122192 - Alvaro; Giuseppe ;   et al. | 2006-06-08 |
Chemical compounds Grant 6,951,861 - Alvaro , et al. October 4, 2 | 2005-10-04 |
Corticotropin releasing factor antagonists App 20050054661 - Di Fabio, Romano ;   et al. | 2005-03-10 |
Chemical compounds App 20040242623 - Difabio, Romano ;   et al. | 2004-12-02 |
Chemical compounds App 20040209893 - Alvaro, Giuseppe ;   et al. | 2004-10-21 |
Tri-and tetraaza-acenaphthylen derivatives as crf receptor antagonists App 20040198726 - Di Fabio, Romano ;   et al. | 2004-10-07 |
Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) App 20040176400 - Capelli, Anna Maria ;   et al. | 2004-09-09 |
Chemical compounds App 20040171607 - Di Fabio, Romano ;   et al. | 2004-09-02 |
Chemical compounds App 20040048862 - Alvaro, Giuseppe ;   et al. | 2004-03-11 |
Treating emesis in a mammal Grant 6,642,240 - Alvaro , et al. November 4, 2 | 2003-11-04 |
Chemical compounds App 20030028021 - Alvaro, Giuseppe ;   et al. | 2003-02-06 |
Low molecular weight bicyclic thrombin inhibitors Grant 6,057,314 - Dimaio , et al. May 2, 2 | 2000-05-02 |
Substituted purinyl derivatives with immunomodulating activity Grant 5,994,361 - Penney , et al. November 30, 1 | 1999-11-30 |
Antineoplastic heteronapthoquinones Grant 5,736,523 - Attardo , et al. April 7, 1 | 1998-04-07 |
Processes antineoplastic heteronaphthoquinones Grant 5,606,037 - Attardo , et al. February 25, 1 | 1997-02-25 |
Heterocyclic anthracycline analogs Grant 5,593,970 - Attardo , et al. January 14, 1 | 1997-01-14 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.